💊AMPAC Fine Chemicals LLC Controlled Substances Application Notice
AMPAC Fine Chemicals LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Cerilliant Corporation's Bulk Manufacturer Application Overview
Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Curia Missouri Inc.'s Application for Controlled Substance Manufacturing
Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️Cerilliant Corporation's Application for Import of Controlled Substances
Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Notice
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Curia New York Applies for Controlled Substances Manufacturing Registration
Curia New York, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️DEA Revocation
The Drug Enforcement Administration revokes the registration of Sasha Melissa Ikramelahai due to allegations of material falsification and lack of state authority to handle controlled substances in North Carolina. The case underscores the significance of regulatory compliance in the healthcare sector, emphasizing the severe consequences businesses face when failing to uphold licensure integrity.
Learn More💊DEA Revokes Pharmacy Registration Due to Compliance Failures
The DEA issued an Order to Show Cause and revoked the registration of Just Here II Pharmacy, citing failures to maintain accurate records for dispensing controlled substances, which poses an imminent danger to public health. The decision emphasizes the importance of compliance with federal and state regulations governing the pharmaceutical industry.
Learn More⚖️High Impact DEA Registration Denial and Compliance Issues
The DEA issued a final order denying Michael Bouknight's applications for DEA registration based on lack of state authority and material falsification in his applications. The ruling highlights the necessity for practitioners to maintain state licensing to handle controlled substances and stresses the importance of integrity in registration processes.
Learn More⚗️DEA Notice on Exempt Chemical Preparations
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2023, and March 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated.
Learn More